Viewing Study NCT04705922



Ignite Creation Date: 2024-05-06 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04705922
Status: COMPLETED
Last Update Posted: 2024-01-03
First Post: 2021-01-06

Brief Title: Relative Bioavailability Study and Food Effect Study of TT-00420 Tinengotinib Capsule and Tablet Formulations in Healthy Volunteers
Sponsor: TransThera Sciences Nanjing Inc
Organization: TransThera Sciences Nanjing Inc

Study Overview

Official Title: A Phase I Single-Center Open-Label 3-Way Crossover Randomized Single Dose Study to Evaluate the Food Effect on the Pharmacokinetics of TT-00420 Tablet and to Determine the Relative Bioavailability of TT-00420 Tablet Versus TT-00420 Capsule in Adult Healthy Volunteers
Status: COMPLETED
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is an open-label 3-way crossover randomized study in adult healthy volunteers to evaluate the relative bioavailability of TT-00420 tablet and capsule formulations and to evaluate food effect on the pharmacokinetics of TT-00420 tablet
Detailed Description: Subjects will be randomized to one of three treatment sequences Each sequence will contain up to 8 subjects In each treatment sequence subjects undergo a baselinescreening period three treatment periods and a follow-up visit

Subjects will be administered a single dose of TT-00420 on Day 1 of either TT-00420 tablet under fed condition TT-00420 tablet under fasting condition or capsule under fasting condition and crossed over after at least a 14-day washout period

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None